Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 1
1954 11
1955 20
1956 15
1957 5
1958 5
1959 6
1960 7
1961 6
1962 2
1963 2
1964 14
1965 8
1966 15
1967 17
1968 13
1969 17
1970 19
1971 18
1972 32
1973 20
1974 14
1975 19
1976 20
1977 20
1978 18
1979 10
1980 30
1981 22
1982 23
1983 16
1984 17
1985 16
1986 13
1987 12
1988 20
1989 13
1990 9
1991 12
1992 17
1993 14
1994 7
1995 7
1996 6
1997 9
1998 5
1999 5
2000 6
2001 9
2002 9
2003 13
2004 8
2005 11
2006 11
2007 12
2008 12
2009 10
2010 9
2011 6
2012 19
2013 7
2014 13
2015 9
2016 12
2017 19
2018 10
2019 9
2020 10
2021 11
2022 17
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

868 results

Results by year

Filters applied: . Clear all
Page 1
Noninferiority Trials.
Garattini S, Bertele’ V. Garattini S, et al. N Engl J Med. 2018 Jan 18;378(3):303. doi: 10.1056/NEJMc1714668. N Engl J Med. 2018. PMID: 29345450 No abstract available.
Pseudo-resistance to anticancer drugs.
Davoli E, Zucchetti M, Giavazzi R, Garattini S, Frapolli R. Davoli E, et al. Among authors: garattini s. Ther Adv Med Oncol. 2022 Nov 14;14:17588359221136776. doi: 10.1177/17588359221136776. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36407785 Free PMC article. No abstract available.
Disappointing biotech.
Joppi R, Bertele' V, Garattini S. Joppi R, et al. Among authors: garattini s. BMJ. 2005 Oct 15;331(7521):895-7. doi: 10.1136/bmj.331.7521.895. BMJ. 2005. PMID: 16223825 Free PMC article. Review.
Conditional approval of medicines by the EMA.
Banzi R, Gerardi C, Bertele' V, Garattini S. Banzi R, et al. Among authors: garattini s. BMJ. 2017 May 2;357:j2062. doi: 10.1136/bmj.j2062. BMJ. 2017. PMID: 28465401 No abstract available.
Funding is not enough.
Garattini S, Bertele' V. Garattini S, et al. Eur J Intern Med. 2018 Nov;57:e8. doi: 10.1016/j.ejim.2018.07.011. Epub 2018 Jul 13. Eur J Intern Med. 2018. PMID: 30017560 No abstract available.
Immunotherapy for colorectal cancer: where are we heading?
Basile D, Garattini SK, Bonotto M, Ongaro E, Casagrande M, Cattaneo M, Fanotto V, De Carlo E, Loupakis F, Urbano F, Negri FV, Pella N, Russano M, Brunetti O, Scartozzi M, Santini D, Silvestris N, Casadei Gardini A, Puzzoni M, Calvetti L, Cardarelli N, Aprile G. Basile D, et al. Among authors: garattini sk. Expert Opin Biol Ther. 2017 Jun;17(6):709-721. doi: 10.1080/14712598.2017.1315405. Epub 2017 Apr 13. Expert Opin Biol Ther. 2017. PMID: 28375039 Free article. Review.
Confidentiality.
Garattini S. Garattini S. Lancet. 2003 Sep 27;362(9389):1078-9. doi: 10.1016/S0140-6736(03)14424-8. Lancet. 2003. PMID: 14522545 No abstract available.
Controlling cervical cancer.
Bonati M, Garattini S. Bonati M, et al. Among authors: garattini s. Pharmacoeconomics. 2009;27(2):91-3. doi: 10.2165/00019053-200927020-00001. Pharmacoeconomics. 2009. PMID: 19254043 No abstract available.
Can systematic reviews contribute to regulatory decisions?
Barbui C, Addis A, Amato L, Traversa G, Garattini S. Barbui C, et al. Among authors: garattini s. Eur J Clin Pharmacol. 2017 Apr;73(4):507-509. doi: 10.1007/s00228-016-2194-y. Epub 2017 Jan 7. Eur J Clin Pharmacol. 2017. PMID: 28064354 Review.
868 results